Taken together, the above results suggest that NSUN2 has the potential to negatively regulate immune cell infiltration in the TME and was negatively correlated with the sensitivity of immunotherapy and chemotherapy drugs for NPC. The gene discussed is NSUN2; the disease is nasopharyngeal carcinoma.